QT Prolongation Risk with Quetiapine and Methadone Co-Administration

Introduction to QT Prolongation Risk

• The European Heart Journal recommends baseline and follow-up ECGs for patients taking methadone, with additional evaluation if daily dosage exceeds 100 mg 1
• Methadone causes pronounced QT prolongation and multiple cases of torsades de pointes have been documented 1

Patient Assessment and Monitoring

• Obtain ECG before initiating quetiapine, and measure electrolytes (potassium, magnesium, calcium) 1, 2
• Assess cardiac history, including syncope, palpitations, and family history of sudden death 1, 5
• Repeat ECG at 2-4 weeks after quetiapine initiation, and annually for stable patients 1, 5

Risk Stratification and Management

• The European Heart Journal and American Academy of Pediatrics recommend avoiding quetiapine in patients with QTc >500 ms, history of torsades de pointes, or congenital long QT syndrome 1, 2
• Consider alternative antipsychotics, such as aripiprazole or olanzapine, in patients with high-risk factors 3
• Monitor electrolytes every 3-6 months, and adjust quetiapine dose or discontinue if QTc >500 ms or increases >60 ms from baseline 1, 2, 3

Safer Alternative Antipsychotics

• Aripiprazole, olanzapine, and risperidone are recommended as safer alternatives to quetiapine due to their lower QT prolongation risk 3

Critical Drug Interactions to Avoid

• Avoid combining methadone and quetiapine with tricyclic antidepressants, due to increased QT prolongation risk 2, 4

Clinical Decision-Making

• The prescriber should obtain immediate ECG and electrolytes, document clinical rationale for choosing quetiapine, and implement a monitoring protocol 2, 3